Clinical Trial Update: Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial evaluating BA058 for treating osteoporosis in postmenopausal women; results were completed and posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• BA058 (abaloparatide)

Snippet

Sponsor: Radius Health, Inc. | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED | Results posted: 2010-07-29